Hungarotrial Zrt
Hungarotrial Zrt is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of iN1011-N17-02 in Patients with Post herpetic Neuralgia (PHN)
Sponsor iN Therapeutics Co. Ltd.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease
Sponsor Amicus Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
An open label, pharmacokinetic and safety study of Combogesic® IV in pediatric patients with acute pain.
Sponsor Aft Pharmaceuticals Limited
- Start (EU)
- Latest update
- Estimated end
A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® plus Standard Medical Treatment Compared to Placebo plus Standard Medical Treatment to Prevent Infections in Patients with Hypogammaglobulinemia and Recurrent or Severe Infections Associated with B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Sponsor Grifols Therapeutics LLC
- Start (EU)
- Latest update
- Estimated end
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Sponsor Universitair Medisch Centrum Utrecht
- Start (EU)
- Latest update
- Estimated end
- Not reported
CATALINA-2: A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6 (CLDN6)
Sponsor Torl Biotherapeutics LLC
- Start (EU)
- Latest update
- Estimated end
A Multinational, Multicenter, Open-label, Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of Oral Paclitaxel (DHP107) Compared to IV Paclitaxel as First-line Therapy in Patients with Recurrent or Metastatic HER2 Negative Breast Cancer
Sponsor Daehwa Pharmaceutical Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration
Sponsor Rophibio Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 3, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Efficacy, Safety, Pharmacokinetics, and Immunogenicity of BP05 Versus EU-Approved Lucentis® in Patients with Wet (Neovascular) Age-Related Macular Degeneration
Sponsor Curateq Biologics Private Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Hungarotrial Zrt?
The 2026-10-09 snapshot links Hungarotrial Zrt to 9 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Project management, Investigator recruitment, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Hungarotrial Zrt?
The most frequently recorded therapeutic areas are Pain Medicine, Genetic and Congenital Disorders, Haematological Malignancies, Immunology. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Hungarotrial Zrt conducted?
The linked trials record locations in 21 countries, including Hungary, Poland, Belgium, Bulgaria, France. These are trial locations, not confirmed office locations or countries where Hungarotrial Zrt delivered services.
What can this page tell me about Hungarotrial Zrt's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under Hungarotrial Zrt. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- HUNGAROTRIAL Zrt.
- Hungarotrial Zrt.